Ageing and dying nowadays: Are there reasons to be optimistic?;Les bienfaits du vieillissement II. Vieillir et mourir de nos jours: Des raisons d'être optimiste?

Revue Medicale de la Suisse Romande

Volumn 121, Issue 9, 2001, Pages 689-695

  Martin Du Pan, Rémy ^a  

^a NONE   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; AGING; DEATH; DEPRESSION; GERIATRICS; HUMAN; PALLIATIVE THERAPY; REVIEW; RISK FACTOR;

AGED; AGED, 80 AND OVER; AGING; DEATH; DEPRESSION; ENGLISH ABSTRACT; GERIATRICS; HUMAN; PALLIATIVE CARE; RISK FACTORS;

EID: 0035464839     PISSN: 00353655     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (63)

1. Wu G.D.: Death and the research imperative. N. Engl. J. Med., 342: 654-653, 2000.
2. Goodwin J.S.: Geriatric ideology; the myth of the myth of senility. J. Am. Geriatr. Soc., 39: 627-631, 1991.
3. Wilmoth J.R., Deegan U., Lundström H., Horiuchi S.: Increase of maximum life-span In Sweden, 1861.1999. Science, 289: 2366-2368, 2000.
4. Vaupel J.-W., Carey J.-R., Christensen K. et al.: Biodemographic trajectories of longevity. Science, 280: 855-859, 1998.
5. Hitt R., Young-Xu Y., Silver M., Perls T.: Centenarians: the older you get, the healtier you have been. Lancet, 354: 652-653, 1999.
6. Olshansky S.J., Carnes B.A., Desesquelles A.: Prospects for human longevity. Science, 291: 149-150, 2001.
7. Nussler W.J., Mackenbach J.P.: Lack of improvement of life expectancy at advanced ages in the Netherlands. Int. J. Epidemiol., 29: 140-148, 2000.
8. Fries J.F.: Aging, natural death, and the compression of morbidity. N. Engl. J. Med., 303: 130-135, 1980.
9. Vita A.J., Terry R.B., Hubert H.B., Fries J.F.: Aging, health risks, and cumulative disability. N. Engl. J. Med., 338: 1035-1041, 1998.
10. Manton K.G., Corder L., Stallard E.: Chronic disability trends in elderly United States populations: 1982-1994. Prod. Natl. Acad. Sci. USA, 94: 2593-2598, 1997.
11. Lao Y., McGee D., Cao G., Cooper R.S.: Quality of the last year of life of older adults: 1986 vs 1993. JAMA, 283: 512-518, 2000.
12. Mathers C.D., Sadana R., Salomon J.A. et al.: Healthy life expectancy in 191 countries, 1999. Lancet, 357: 1685-1691, 2001.
13. Knopman D., Boland L.L., Mosley T. et al.: Cardiovascular risk factors and cognitive decline in middle-aged adults. Neurology, 6: 42-48, 2001.
14. Miettinen T.A., Pyörälä K., Olson A.G. et al.: Cholesterol lowering therapy in women and elderly patients with myocardial infarction angor angina pectoris: findings from the SSS study. Circulation, 96: 4211-4218, 1997.
15. Lewis S.J., Moye L.A., Sacks F.M. et al.: Effect of pravastatin on cardiovascular events in older patients with myocardial infarction and cholesterol levels in the average range. Ann. Intern. Med., 129: 681-689, 1998.
16. Jialal I., Stein D., Balis D. et al.: Effect of HMGCoA reductase inhibitor therapy on hs-CRP levels. Circulation, 103: 1933-1935, 2001.
17. Jick H., Zornberg G.L., Jick S.S., Seshadri S., Drachman D.A.: Statins and the risk of dementia. Lancet, 356: 1627-1631, 2000.
18. Shepherd J., Blauw G.J., Murphy M.B. et al.: The design of a propective study of pravastatin in the elderly at risk (PROSPER). Am. J. Cardiol., 84: 1192-1197, 1999.
19. Staessen J.A., Gasowski J., Wang J.G., Thijs L. et al.: Risks of untreated and treated isolated systolic hypertension in the elderly: meta-analysis of outcome trials. Lancet, 355: 865-872, 2000.
20. Mulrow C, Lau J., Cornell J., Brand M.: Pharmacotherapy for hypertension in the elderly. Cochrane Database Syst. Rev. 2000; (2) CD, 000028.
21. Conwell Y., Lyness J.M., Duberstein P. et al.: Completed suicide among older patients in primary care practices a controlled study. J. Am. Geriatr. Soc., 48: 23-29, 2000.
22. Unützer J., Simon G., Belin T.R., Datt M. et al.: Care for depression in HMO patients aged 65 and older. J. Am. Geriatr. Soc., 48: 871-878, 2000.
23. Copeland J.R.M., Beekmann A.T.F., Dewey M.E. et al.: Depression in Europe. Geographical distribution among elder people. Brit. J. Psych., 174: 312-321, 1999.
24. Copeland J.R.M., Beekmann A.T.F., Dewey M.E. et al.: Cross-cultural comparison of depressive symptoms in Europe does not support stereotypes of ageing. Brit. J. Psych., 174: 322-329, 1999.
25. Centre interfacultaire de gérontologie de l'Université de Genève. La vie après 80 ans. No 5 sept. 2000.
26. Ostir G.V., Markides K.S., Black S.A., Goodwin J.S.: Emotional well-being predicts subsequent functional independence and survival. J. Am. Geriatr. Soc., 48: 473-478, 2000.
27. Penninx B.W.J.H., Guralnick J.M., Bandeen-Roche K. et al.: The protective effect of emotional vitality on adverse health outcomes in disabled older women. J. Am. Geriatr. Soc., 48: 1359-1366, 2000.
28. Kiely D.K., Simon S.E., Jones R.N., Morris J.-N.: The protective effect of social engagement on mortality in long-term care. J. Am. Geriatr. Soc., 48: 1367-1372, 2000.
29. Rozanski A., Blumenthal J.A., Kaplan J.: Impact of pyschological factors on the pathogenesis of cardiovascular disease and implications for therapy. Circulation, 99: 2192-2217, 1999.
30. Balducci L., Extermann M.: Cancer and aging. Hematol. Oncol. Clin. North Am., 14: 1-10, 2000.
31. DePinto R.A.: The age of cancer. Nature, 408: 248-254, 2000.
32. Zulian G.B.: Les aspects particuliers du cancer après 80 ans. Geriatr. Prat., 3: 29-30, 2000.
33. Kimmick G.G., Balducci L.: Breast cancer and aging. Hematol. Oncol. Iin. Noth Am., 14: 213-233, 2000.
34. Ershlker W.B., Longo D.L.: Aging and cancer: issues of basic and clinical science. J. Natl. Cancer Inst., 89: 1489-1497,1997.
35. Stewart T., Tsai S.C.J., Grayson H., Henderson R., Opelz G.: Incidence of de-novo breast cancer in women chronically immunosuppressed after organ transplantation. Lancet, 346: 796-798, 1995.
36. Martin-du Pan R.-C.: Les hormones de jouvence sont-elles cancérigènes? Ann. Endocrinol., 60: 392-397, 1999.
37. Lengauer C., Kinzler C.W., Vogelstein B.: Genetic instabilities in human cancers. Nature, 396: 643-648, 1998.
38. Urquidi V., Tarin D., Goodison S.: Role of telomerase in cell senescence and oncogenesis. Ann. Rev. Med., 51: 65-79, 2000.
39. Bodnar A.G., Ouellette M., Frolkis M., Holt S.E. et al.: Extension of life-span by introduction of telomerase into normal human cells. Science, 279: 334-335, 1998.
40. Kapp C.: Swiss allow assisted suicide, but what about euthanasia? Lancet, 354: 2059, 1999.
41. Roy D.J., Rapin C.-H.: A propos de l'euthanasie. Eur. J. Palliat. Care, 1: 57-59
42. Neuenschwander H., Steiner N., Stiefel F. et al.: Médecine palliative en un coup d'œil. Ligue Suisse contre le Cancer, 1999.
43. Quill T.E., Dresser R., Brock D.W.: The rule of double effect a critique of its role in end-of-life decision making. N. Engl. J. Med., 337: 1767-1771, 1997.
44. Thorns A. Sykes N.: Opioid use in last week of life and implications for end-of-life decision making. Lancet, 356: 398-399, 2000.
45. Olmari-Ebbing M., Zumbach C.-N., Forest M.I., Rapin C.-H.: Les directives anticipées, un outil d'humanisation des soins. Rev. méd. Suisse rom., 120: 581-584, 2000.
46. Chochinov H.M., Tataryn D., Clinch J.J., Dudgeon D.: Will to live in the terminally ill. Lancet, 354: 816-820, 1999.
47. Eychmuller S., Raemy-Bass C.: Bestandesaufnahme zur Situation von Palliative Care in der Schweiz. Primary Care, 1: 272-275, 2001.
48. e congrès Ass. Eur. Soins Pall. Genève sept. 99 (Abstract).
49. Zech D.F., Grand S., Hertel D. et al.: Validation of WHO guidelines for cancer pain relief: a 10 year prospective study. Pain, 63: 65-76, 1995.
50. Heim A.: Notizen ueber den Tod durch Absturz. Jahrb. Schweiz. Alpenklub., 27: 327, 1892.
51. Moody R.: La Vie après la vie. Rob. Laffont, 1977.
52. Greyson B., Stevenson I.: The phenomenology of near-death experiences. Am. J. Psychiatry, 137: 1193-1196, 1980.
53. Parnia S., Waller D.G., Yeates R., Fenwick P.: A qualitative and quantitative study of the incidence, features and aetiology of near death experiences in cardiac arrest survivors. Ressuscitation, 48: 149-156, 2001.
54. Morse M., Castillo P., Venecia D. et al.: Childhood near-death experiences. AJDC, 140: 1110-1114, 1986.
55. Owens J.E., Cook E.W., Stevenson I.: Features of «near-death experience» in relation to whether or not patients were near death. Lancet, 336: 1175-1177, 1990.
56. Dobson M., Tattersfield A.E. Adler M.W. et al.: Attitudes and long-term adjustment of patients surviving cardiac arrest. Brit. Med. J., 3: 207-212, 1971.
57. Greyson B.: Dissociation in people who have near-death experiences:out of their bodies or out of their minds? Lancet, 355: 460-463, 2000.
58. Jansen K.L.R.: Neuroscience and the near-death experience: roles for the NMSA-PCP receptor, the sigma receptor and the endopsychosins. Medical Hypotheses, 31: 25-29, 1990.
59. Combaz C.: Eloge de l'âge. Fayard, 2000.
60. Gromolard A.: Accomplir sa vie. L'Essentiel - Chronique Sociale - Nov. 2000.
61. de Saussure C.: Vieillard martyrs, vieillards tirelires. Maltraitance des personnes âgées. Ed. Médecine et Hygiène, 1999.
62. Lalive d'Epinay C.: Vieillir ou la vie à inventer. Ed. L'Harmattan, 1991.
63. Hassed C.: How humour keeps you well. Aust. Fam. Physician, 30; 25-28, 2001.